This document is page 158 of a Cannabis Investment Report dated December 2017, published by Ackrell Capital, LLC. It profiles four companies operating in the cannabis industry: Rubicon Organics, S2S Development, SC Laboratories, and Scrubbed, providing their locations, websites, and brief business descriptions. The document bears the Bates stamp HOUSE_OVERSIGHT_024794, indicating it is part of a House Oversight Committee production.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Author of the Cannabis Investment Report
|
|
| Rubicon Organics |
Licensed cannabis cultivator based in Bellingham, Washington
|
|
| S2S Development |
Contract manufacturer and distributor based in San Francisco
|
|
| SC Laboratories |
Cannabis lab-testing company based in Santa Cruz
|
|
| Scrubbed |
Outsourced bookkeeping and tax firm based in San Francisco
|
|
| FINRA |
Mentioned in footer regarding Ackrell Capital membership
|
|
| SIPC |
Mentioned in footer regarding Ackrell Capital membership
|
|
| FDA |
Mentioned in SC Laboratories description regarding testing guidelines
|
| Location | Context |
|---|---|
"Rubicon Organics is a licensed cannabis cultivator specializing in the growing, processing, packaging and marketing of cannabis."Source
"S2S Development is a contract manufacturer and distributor of cannabis products."Source
"SC Laboratories is a cannabis lab-testing company... adhering to FDA and other guidelines in its testing."Source
"Scrubbed is an outsourced bookkeeping, accounting and tax firm serving the cannabis industry."Source
Complete text extracted from the document (1,401 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document